Peter M Black

Author PubWeight™ 120.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002 15.36
2 Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 2003 8.06
3 Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012 2.84
4 Epidemiology of intracranial meningioma. Neurosurgery 2005 2.60
5 A 24-year-old woman with intractable seizures: review of surgery for epilepsy. JAMA 2008 2.55
6 The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. J Clin Oncol 2004 2.24
7 Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance. Cancer 2005 1.97
8 Neurosurgery certification in member societies of the WFNS: global overview. World Neurosurg 2011 1.87
9 Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 2003 1.65
10 History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002 1.62
11 Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro Oncol 2006 1.57
12 A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastoma. Cancer Res 2006 1.54
13 Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res 2009 1.52
14 DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 2009 1.51
15 Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 2005 1.50
16 Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973-2001. Cancer 2006 1.49
17 Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 2006 1.44
18 Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology 2006 1.42
19 Non-rigid alignment of pre-operative MRI, fMRI, and DT-MRI with intra-operative MRI for enhanced visualization and navigation in image-guided neurosurgery. Neuroimage 2006 1.41
20 In vitro and in vivo activity of the nuclear factor-kappaB inhibitor sulfasalazine in human glioblastomas. Clin Cancer Res 2004 1.40
21 Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 2009 1.40
22 Immediate titanium mesh cranioplasty for treatment of postcraniotomy infections. World Neurosurg 2011 1.39
23 Neurosurgery certification in member societies of the WFNS: Europe. World Neurosurg 2011 1.39
24 Targeting rat brainstem glioma using human neural stem cells and human mesenchymal stem cells. Clin Cancer Res 2009 1.38
25 Capturing intraoperative deformations: research experience at Brigham and Women's Hospital. Med Image Anal 2004 1.35
26 Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 2003 1.28
27 SNAI2/Slug promotes growth and invasion in human gliomas. BMC Cancer 2010 1.26
28 Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 2008 1.26
29 Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev 2006 1.23
30 Exogenous hormone use and meningioma risk: what do we tell our patients? Cancer 2007 1.20
31 Aberrant splicing of cyclin-dependent kinase-associated protein phosphatase KAP increases proliferation and migration in glioblastoma. Cancer Res 2007 1.17
32 Polymorphisms in apoptosis and cell cycle control genes and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2007 1.17
33 Continuous intracranial administration of suberoylanilide hydroxamic acid (SAHA) inhibits tumor growth in an orthotopic glioma model. J Neurooncol 2007 1.15
34 Image-guided neurosurgery at Brigham and Women's Hospital. IEEE Eng Med Biol Mag 2006 1.14
35 Oxidative response gene polymorphisms and risk of adult brain tumors. Neuro Oncol 2008 1.13
36 PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 2005 1.08
37 High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. Int J Oncol 2010 1.07
38 Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J 2003 1.05
39 Matrix solution fixation: histology-compatible tissue preparation for MALDI mass spectrometry imaging. Anal Chem 2007 1.05
40 Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res 2010 1.04
41 Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche. Brain Res 2009 1.03
42 Neurosurgery certification in member societies of the World Federation of Neurosurgical Societies: Asia. World Neurosurg 2011 1.03
43 Techniques and complications of external lumbar drainage for normal pressure hydrocephalus. Neurosurgery 2008 1.02
44 Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 2008 1.02
45 The Harvard Neurosurgical Service at the Children's Hospital Boston and Brigham & Women's Hospital, 1912-2007. Neurosurgery 2008 1.00
46 Solid-state NMR adiabatic TOBSY sequences provide enhanced sensitivity for multidimensional high-resolution magic-angle-spinning 1H MR spectroscopy. J Magn Reson 2008 0.99
47 Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia. Ann Neurol 2012 0.98
48 Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies. Int J Mol Med 2007 0.97
49 Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev 2003 0.97
50 A recurrent craniopharyngioma illustrates the potential usefulness of urinary matrix metalloproteinases as noninvasive biomarkers: case report. Neurosurgery 2007 0.97
51 Sociodemographic indicators and risk of brain tumours. Int J Epidemiol 2003 0.97
52 Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls. Int J Cancer 2011 0.96
53 Variation in genes relevant to aromatic hydrocarbon metabolism and the risk of adult brain tumors. Neuro Oncol 2006 0.93
54 Origins of intraoperative MRI. Neurosurg Clin N Am 2009 0.91
55 Imaging of meningioma progression by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Anal Chem 2010 0.91
56 A pilot safety study of lenalidomide and radiotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2008 0.90
57 Occupation and risk of meningioma and acoustic neuroma in the United States. Am J Ind Med 2004 0.90
58 The development of ring-shaped contrast enhancement in a case of cerebellar dysembryoplastic neuroepithelial tumor: case report. Neurosurgery 2008 0.90
59 Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia 2012 0.89
60 Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations. Brain Pathol 2007 0.88
61 In vivo fate and therapeutic efficacy of PF-4/CTF microspheres in an orthotopic human glioblastoma model. FASEB J 2007 0.88
62 Genetic variation in insulin-like growth factors and brain tumor risk. Neuro Oncol 2008 0.87
63 Local delivery of poly lactic-co-glycolic acid microspheres containing imatinib mesylate inhibits intracranial xenograft glioma growth. Clin Cancer Res 2009 0.86
64 A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain. Curr Med Res Opin 2004 0.85
65 Delta-aminolevulinic acid dehydratase polymorphism and risk of brain tumors in adults. Environ Health Perspect 2005 0.85
66 Compensation of geometric distortion effects on intraoperative magnetic resonance imaging for enhanced visualization in image-guided neurosurgery. Neurosurgery 2008 0.85
67 Statistical validation of brain tumor shape approximation via spherical harmonics for image-guided neurosurgery. Acad Radiol 2005 0.85
68 Handedness and risk of brain tumors in adults. Cancer Epidemiol Biomarkers Prev 2003 0.84
69 Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Int J Alzheimers Dis 2011 0.84
70 Occupational exposure to magnetic fields and the risk of brain tumors. Neuro Oncol 2009 0.84
71 Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam. J Clin Psychopharmacol 2003 0.84
72 Origins of intraoperative MRI. Magn Reson Imaging Clin N Am 2010 0.82
73 Establishment of an in vivo meningioma model with human telomerase reverse transcriptase. Neurosurgery 2007 0.82
74 A double-blind randomized controlled trial of rofecoxib and multidose oxycodone/acetaminophen in dental impaction pain. J Oral Maxillofac Surg 2007 0.82
75 Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. Am J Epidemiol 2006 0.82
76 Meningioma and schwannoma risk in adults in relation to family history of cancer. Neuro Oncol 2004 0.81
77 Self-reported electrical appliance use and risk of adult brain tumors. Am J Epidemiol 2005 0.80
78 Simple partial seizures with hemisensory phenomena and dysgeusia: an insular pattern. Epilepsia 2005 0.80
79 A new metric for detecting change in slowly evolving brain tumors: validation in meningioma patients. Neurosurgery 2011 0.80
80 Polio vaccination and risk of brain tumors in adults: no apparent association. Cancer Epidemiol Biomarkers Prev 2003 0.79
81 Metacognition and false recognition in patients with frontal lobe lesions: the distinctiveness heuristic. Neuropsychologia 2005 0.79
82 Surgery for convexity meningiomas. Neurosurgery 2008 0.79
83 Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers. Int J Oncol 2008 0.79
84 A low-field intraoperative MRI system for glioma surgery: is it worthwhile? Neurosurg Clin N Am 2005 0.78
85 Novel local drug delivery system using thermoreversible gel in combination with polymeric microspheres or liposomes. Anticancer Res 2010 0.78
86 Imaging of human mesenchymal stromal cells: homing to human brain tumors. J Neurooncol 2011 0.77
87 Functional recovery in T13-L1 hemisected rats resulting from peripheral nerve rerouting: role of central neuroplasticity. Regen Med 2008 0.77
88 Diagnostic retrieval monitoring in patients with frontal lobe lesions: further exploration of the distinctiveness heuristic. Neuropsychologia 2007 0.77
89 Inhibition of thromboxane synthase activity improves glioblastoma response to alkylation chemotherapy. Transl Oncol 2010 0.77
90 Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone. Int J Oncol 2011 0.76
91 Selected human leukocyte antigen class II polymorphisms and risk of adult glioma. J Neuroimmunol 2010 0.75
92 World Neurosurgery Neurosurgeon of the Year 2012: Liangfu Zhou. World Neurosurg 2012 0.75
93 Al Rhoton as neurosurgeon of the year. World Neurosurg 2011 0.75
94 Neurosurgery certification in member societies of the World Federation of Neurosurgical Societies (WFNS). The Americas. World Neurosurg 2010 0.75
95 Psychiatric diseases, informed consent, psychosurgery: a reply to Dr. Thomas Szasz. Humanist 1979 0.75
96 Madjid Samii: neurosurgeon of the year 2013. World Neurosurg 2013 0.75
97 Anaplastic variant of medulloblastoma mimicking a vestibular schwannoma. J Neurooncol 2006 0.75
98 The rationale for psychosurgery. Humanist 1979 0.75
99 Detection of unanticipated intracranial hemorrhage during intraoperative magnetic resonance image-guided neurosurgery. Report of two cases. J Neurosurg 2007 0.75
100 Neurosurgery certification in member societies of the WFNS: Africa and the Middle East. World Neurosurg 2011 0.75
101 DNA repair enzyme expression and differential response to temozolomide in a patient with both glioblastoma and metastatic pancreatic neuroendocrine tumor. J Clin Oncol 2008 0.75
102 The management of skull base tumors. Handb Clin Neurol 2012 0.75